世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
医療用プラスチック市場。世界の産業動向、シェア、サイズ、成長、機会、そして2021-2026年の予測Medical Plastics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global medical plastics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the u... もっと見る
サマリーThe global medical plastics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.Medical plastics refer to various polymeric materials manufactured specifically for healthcare applications. They are commonly used for tamper-proof caps, vials, beakers, inhalations masks, bedpans, intravenous (IV) tubes, pill casings, surgical instruments, prosthetics and catheters. Some of the commonly used variants include silicon, synthetic rubber, polymer blends, high performance and engineering plastics. They are produced using hypoallergenic, biocompatible, medical-grade polypropylene and polycarbonate materials. They are shatter-proof, non-permeable, temperature, chemical and corrosion-resistant and can have frequent sterilization cycles. Medical plastics can also be used to transport biohazardous materials as they have antimicrobial surfaces and can aid in preventing the spread of pathogens. Global Medical Plastics Market Trends: Significant growth in the medical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for single-use medical plastics and consumables in the healthcare centers. Hospitals, diagnostic centers and clinics are extensively using thermal scanners, ventilators, gloves, respirators and masks for the treatment of the patients. Additionally, various product innovations, such as the development of medical plastics with enhanced biocompatibility, are acting as other growth-inducing factors. These novel variants are more cost-effective and are used in targeted drug delivery systems for the controlled release of drugs in complex parts of the brain and to treat various degenerative diseases. Other factors, including extensive improvements in the healthcare infrastructure, especially in the developing economies, along with the rising geriatric population, are anticipated to drive the market further. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global medical plastics market, along with forecasts at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, material and application. Breakup by Material: Polyvinyl Chloride (PVC) Polypropylene (PP) Engineering Plastics Polyethylene (PE) Polystyrene (PS) Silicones Others Breakup by Application: Disposables Drug Delivery Devices Diagnostic Instruments Catheters Surgical Instruments Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Arkema SA, BASF SE, Celanese Corporation, Covestro AG, Dow Inc, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.) and Trinseo S.A. Key Questions Answered in This Report: How has the global medical plastics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global medical plastics market? What are the key regional markets? What is the breakup of the market based on the material? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global medical plastics market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Medical Plastics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Material 6.1 Polyvinyl Chloride (PVC) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Polypropylene (PP) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Engineering Plastics 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Polyethylene (PE) 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Polystyrene (PS) 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Silicones 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 Others 6.7.1 Market Trends 6.7.2 Market Forecast 7 Market Breakup by Application 7.1 Disposables 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Drug Delivery Devices 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Diagnostic Instruments 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Catheters 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Surgical Instruments 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Others 7.6.1 Market Trends 7.6.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Arkema SA 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 BASF SE 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.2.4 SWOT Analysis 13.3.3 Celanese Corporation 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 Financials 13.3.3.4 SWOT Analysis 13.3.4 Covestro AG 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.4.3 Financials 13.3.5 Dow Inc 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.5.3 Financials 13.3.6 DuPont de Nemours Inc 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.6.3 Financials 13.3.6.4 SWOT Analysis 13.3.7 Evonik Industries AG 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.7.3 Financials 13.3.7.4 SWOT Analysis 13.3.8 Exxon Mobil Corporation 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.8.3 Financials 13.3.9 SABIC 13.3.9.1 Company Overview 13.3.9.2 Product Portfolio 13.3.9.3 Financials 13.3.9.4 SWOT Analysis 13.3.10 Solvay S.A. 13.3.10.1 Company Overview 13.3.10.2 Product Portfolio 13.3.10.3 Financials 13.3.10.4 SWOT Analysis 13.3.11 The Lubrizol Corporation (Berkshire Hathaway Inc.) 13.3.11.1 Company Overview 13.3.11.2 Product Portfolio 13.3.11.3 SWOT Analysis 13.3.12 Trinseo S.A. 13.3.12.1 Company Overview 13.3.12.2 Product Portfolio 13.3.12.3 Financials
SummaryThe global medical plastics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.Medical plastics refer to various polymeric materials manufactured specifically for healthcare applications. They are commonly used for tamper-proof caps, vials, beakers, inhalations masks, bedpans, intravenous (IV) tubes, pill casings, surgical instruments, prosthetics and catheters. Some of the commonly used variants include silicon, synthetic rubber, polymer blends, high performance and engineering plastics. They are produced using hypoallergenic, biocompatible, medical-grade polypropylene and polycarbonate materials. They are shatter-proof, non-permeable, temperature, chemical and corrosion-resistant and can have frequent sterilization cycles. Medical plastics can also be used to transport biohazardous materials as they have antimicrobial surfaces and can aid in preventing the spread of pathogens. Global Medical Plastics Market Trends: Significant growth in the medical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for single-use medical plastics and consumables in the healthcare centers. Hospitals, diagnostic centers and clinics are extensively using thermal scanners, ventilators, gloves, respirators and masks for the treatment of the patients. Additionally, various product innovations, such as the development of medical plastics with enhanced biocompatibility, are acting as other growth-inducing factors. These novel variants are more cost-effective and are used in targeted drug delivery systems for the controlled release of drugs in complex parts of the brain and to treat various degenerative diseases. Other factors, including extensive improvements in the healthcare infrastructure, especially in the developing economies, along with the rising geriatric population, are anticipated to drive the market further. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global medical plastics market, along with forecasts at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, material and application. Breakup by Material: Polyvinyl Chloride (PVC) Polypropylene (PP) Engineering Plastics Polyethylene (PE) Polystyrene (PS) Silicones Others Breakup by Application: Disposables Drug Delivery Devices Diagnostic Instruments Catheters Surgical Instruments Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Arkema SA, BASF SE, Celanese Corporation, Covestro AG, Dow Inc, DuPont de Nemours Inc, Evonik Industries AG, Exxon Mobil Corporation, SABIC, Solvay S.A., The Lubrizol Corporation (Berkshire Hathaway Inc.) and Trinseo S.A. Key Questions Answered in This Report: How has the global medical plastics market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global medical plastics market? What are the key regional markets? What is the breakup of the market based on the material? What is the breakup of the market based on the application? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global medical plastics market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Medical Plastics Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Material 6.1 Polyvinyl Chloride (PVC) 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Polypropylene (PP) 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Engineering Plastics 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Polyethylene (PE) 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Polystyrene (PS) 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Silicones 6.6.1 Market Trends 6.6.2 Market Forecast 6.7 Others 6.7.1 Market Trends 6.7.2 Market Forecast 7 Market Breakup by Application 7.1 Disposables 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Drug Delivery Devices 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Diagnostic Instruments 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Catheters 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Surgical Instruments 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Others 7.6.1 Market Trends 7.6.2 Market Forecast 8 Market Breakup by Region 8.1 North America 8.1.1 United States 8.1.1.1 Market Trends 8.1.1.2 Market Forecast 8.1.2 Canada 8.1.2.1 Market Trends 8.1.2.2 Market Forecast 8.2 Asia-Pacific 8.2.1 China 8.2.1.1 Market Trends 8.2.1.2 Market Forecast 8.2.2 Japan 8.2.2.1 Market Trends 8.2.2.2 Market Forecast 8.2.3 India 8.2.3.1 Market Trends 8.2.3.2 Market Forecast 8.2.4 South Korea 8.2.4.1 Market Trends 8.2.4.2 Market Forecast 8.2.5 Australia 8.2.5.1 Market Trends 8.2.5.2 Market Forecast 8.2.6 Indonesia 8.2.6.1 Market Trends 8.2.6.2 Market Forecast 8.2.7 Others 8.2.7.1 Market Trends 8.2.7.2 Market Forecast 8.3 Europe 8.3.1 Germany 8.3.1.1 Market Trends 8.3.1.2 Market Forecast 8.3.2 France 8.3.2.1 Market Trends 8.3.2.2 Market Forecast 8.3.3 United Kingdom 8.3.3.1 Market Trends 8.3.3.2 Market Forecast 8.3.4 Italy 8.3.4.1 Market Trends 8.3.4.2 Market Forecast 8.3.5 Spain 8.3.5.1 Market Trends 8.3.5.2 Market Forecast 8.3.6 Russia 8.3.6.1 Market Trends 8.3.6.2 Market Forecast 8.3.7 Others 8.3.7.1 Market Trends 8.3.7.2 Market Forecast 8.4 Latin America 8.4.1 Brazil 8.4.1.1 Market Trends 8.4.1.2 Market Forecast 8.4.2 Mexico 8.4.2.1 Market Trends 8.4.2.2 Market Forecast 8.4.3 Others 8.4.3.1 Market Trends 8.4.3.2 Market Forecast 8.5 Middle East and Africa 8.5.1 Market Trends 8.5.2 Market Breakup by Country 8.5.3 Market Forecast 9 SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10 Value Chain Analysis 11 Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12 Price Analysis 13 Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Arkema SA 13.3.1.1 Company Overview 13.3.1.2 Product Portfolio 13.3.1.3 Financials 13.3.1.4 SWOT Analysis 13.3.2 BASF SE 13.3.2.1 Company Overview 13.3.2.2 Product Portfolio 13.3.2.3 Financials 13.3.2.4 SWOT Analysis 13.3.3 Celanese Corporation 13.3.3.1 Company Overview 13.3.3.2 Product Portfolio 13.3.3.3 Financials 13.3.3.4 SWOT Analysis 13.3.4 Covestro AG 13.3.4.1 Company Overview 13.3.4.2 Product Portfolio 13.3.4.3 Financials 13.3.5 Dow Inc 13.3.5.1 Company Overview 13.3.5.2 Product Portfolio 13.3.5.3 Financials 13.3.6 DuPont de Nemours Inc 13.3.6.1 Company Overview 13.3.6.2 Product Portfolio 13.3.6.3 Financials 13.3.6.4 SWOT Analysis 13.3.7 Evonik Industries AG 13.3.7.1 Company Overview 13.3.7.2 Product Portfolio 13.3.7.3 Financials 13.3.7.4 SWOT Analysis 13.3.8 Exxon Mobil Corporation 13.3.8.1 Company Overview 13.3.8.2 Product Portfolio 13.3.8.3 Financials 13.3.9 SABIC 13.3.9.1 Company Overview 13.3.9.2 Product Portfolio 13.3.9.3 Financials 13.3.9.4 SWOT Analysis 13.3.10 Solvay S.A. 13.3.10.1 Company Overview 13.3.10.2 Product Portfolio 13.3.10.3 Financials 13.3.10.4 SWOT Analysis 13.3.11 The Lubrizol Corporation (Berkshire Hathaway Inc.) 13.3.11.1 Company Overview 13.3.11.2 Product Portfolio 13.3.11.3 SWOT Analysis 13.3.12 Trinseo S.A. 13.3.12.1 Company Overview 13.3.12.2 Product Portfolio 13.3.12.3 Financials
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（産業機械）の最新刊レポート
IMARC Services Private Limited.社のその他分野での最新刊レポート
本レポートと同じKEY WORD（industry）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/27 10:26 153.88 円 161.83 円 196.22 円 |
